SEC Info - Hong Yuan Holding Group - ‘10-Q’ for 9/30/22

Page	(sequential)		(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Condensed Consolidated Financial Statements (Unaudited) Controls and Procedures Defaults Upon Senior Securities Exhibits Financial Information Legal Proceedings Management's Discussion and Analysis of Financial Condition and Results of Operations Mine Safety Disclosures Other Information Part I -- Financial Information Part Ii -- Other Information Quantitative and Qualitative Disclosures About Market Risk Risk Factors Unregistered Sales of Equity Securities and Use of Proceeds
1	1st Page – Filing Submission
"	Part I -- Financial Information
"	Condensed Consolidated Financial Statements (Unaudited)
"	Management's Discussion and Analysis of Financial Condition and Results of Operations
"	Quantitative and Qualitative Disclosures About Market Risk
"	Controls and Procedures
"	Part Ii -- Other Information
"	Legal Proceedings
"	Risk Factors
"	Unregistered Sales of Equity Securities and Use of Proceeds
"	Defaults Upon Senior Securities
"	Mine Safety Disclosures
"	Exhibits

i 0001324759 i false i --12-31 i Q3 i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i 0001324759 2022-01-01 2022-09-30 0001324759 2022-11-09 0001324759 2022-09-30 0001324759 2021-12-31 0001324759 2022-07-01 2022-09-30 0001324759 2021-07-01 2021-09-30 0001324759 2021-01-01 2021-09-30 0001324759 us-gaap:CommonStockMember 2021-12-31 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2021-12-31 0001324759 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001324759 us-gaap:RetainedEarningsMember 2021-12-31 0001324759 us-gaap:CommonStockMember 2022-06-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2022-06-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001324759 us-gaap:RetainedEarningsMember 2022-06-30 0001324759 2022-06-30 0001324759 us-gaap:CommonStockMember 2020-12-31 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2020-12-31 0001324759 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001324759 us-gaap:RetainedEarningsMember 2020-12-31 0001324759 2020-12-31 0001324759 us-gaap:CommonStockMember 2021-06-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2021-06-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001324759 us-gaap:RetainedEarningsMember 2021-06-30 0001324759 2021-06-30 0001324759 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2022-01-01 2022-06-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001324759 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001324759 2022-01-01 2022-06-30 0001324759 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2022-07-01 2022-09-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001324759 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001324759 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2021-01-01 2021-06-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001324759 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001324759 2021-01-01 2021-06-30 0001324759 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2021-07-01 2021-09-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001324759 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001324759 us-gaap:CommonStockMember 2022-09-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2022-09-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001324759 us-gaap:RetainedEarningsMember 2022-09-30 0001324759 us-gaap:CommonStockMember 2021-09-30 0001324759 us-gaap:PreferredStockMember HGYN:SeriesA1PreferredStockMember 2021-09-30 0001324759 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001324759 us-gaap:RetainedEarningsMember 2021-09-30 0001324759 2021-09-30 0001324759 2014-01-30 2014-01-31 0001324759 HGYN:CustodianVenturesLLCMember us-gaap:CommonStockMember 2019-10-03 2019-10-04 0001324759 HGYN:CustodianVenturesLLCMember us-gaap:CommonStockMember 2019-10-04 0001324759 us-gaap:SeriesAPreferredStockMember 2020-04-13 2020-04-14 0001324759 us-gaap:CommonStockMember 2020-04-13 2020-04-14 0001324759 us-gaap:SeriesAPreferredStockMember 2020-04-15 0001324759 HGYN:SeriesA1PreferredStockMember 2020-05-01 0001324759 HGYN:SeriesA1PreferredStockMember HGYN:CustodianVenturesLLCMember 2020-05-03 2020-05-04 0001324759 us-gaap:CommonStockMember 2020-11-02 2020-11-03 0001324759 HGYN:SeriesA1PreferredStockMember 2020-11-02 2020-11-03 0001324759 us-gaap:MajorityShareholderMember 2022-09-30 0001324759 us-gaap:MajorityShareholderMember 2021-12-31 0001324759 HGYN:CustodianVenturesLLCMember us-gaap:CommonStockMember 2021-05-25 2021-05-27 0001324759 HGYN:SeriesA1PreferredStockMember 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. i Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically on its corporate Web site, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ i No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). i Yes ☒ No ☐

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. The number of shares outstanding of the registrant’s common stock as of November 9, 2022 was i 74,640,766.

This Quarterly Report includes forward-looking statements within the meaning of the Securities Exchange Act of 1934 (the “Exchange Act”). These statements are based on management’s beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements also include statements in which words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “consider” or similar expressions are used.

Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Certain statements made in this Quarterly Report on Form 10-Q are “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding the plans and objectives of management for future operations. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Crown Marketing, (“we”, “us”, “our” or the “Company”) to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. The Company’s plans and objectives are based, in part, on assumptions involving the continued expansion of business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes its assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance the forward-looking statements included in this Quarterly Report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved.

The Company was incorporated in the state of Nevada on September 14, 2001 under the name Biocorp North America, Inc. On July 19, 2004 the Company changed its name to Nat-UR, Inc. and on March 18, 2005 it changed its name again to Cereplast, Inc. In the summer of 2014, the Company ceased all operations.

On March 22, 2019, the eight judicial District Court of Nevada appointed Custodian Ventures, LLC as custodian for Cereplast, Inc., proper notice having been given to the officers and directors of Cereplast, Inc. There was no opposition.

On June 04, 2019, the Company filed a certificate of revival with the state of Nevada, appointing David Lazar as, President, Secretary, Treasurer and Director.

A change of control of the Company was completed on November 3, 2020, control was obtained by the sale of 50,000,000 common shares and $5,000,000 Series A-1 Preferred Shares from Custodian Ventures, LLC to Xudong Li. After November 3, 2020, the Company’s operations are determined and structured by the new major shareholder.

We have not yet generated sustained profits from our prior operations. Our independent accountants have expressed a “going concern” opinion. As of September 30, 2022, we had an accumulated deficit of $97,354,888 and a net working capital deficit of $89,211.

While our current burn rate is nominal, it is expected that our costs of operations will continue to exceed revenues, primarily due to the costs associated with being a public reporting company. Based upon our current business plan, we may continue to incur losses in the foreseeable future and there can be no assurances that we will ever establish profitable operations. These and other factors raise substantial doubt about our ability to continue as a going concern.

The Company is planning potential acquisitions. The management has approached several companies in China and met the management of potential acquisition targets. The Company feels strongly that despite the challenges of cross border business, it might be able to acquire some good growth companies and bring good values to our stockholders. Although the Company is making some progress in the Merger and Acquisition efforts, any potential results, if any, are still not certain.

Our discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). The preparation of these consolidated financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

An accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in the accounting estimate that are reasonably likely to occur, could materially impact the consolidated financial statements. We believe that the following critical accounting policies reflect the more significant estimates and assumptions used in the preparation of the consolidated financial statements.

ASU No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), became effective for the Company on January 1, 2018 and were adopted using the modified retrospective method. The adoption of the new revenue standards as of January 1, 2018 did not change the Company’s revenue recognition as there were no revenues during the period.

Under the new revenue standards, the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the five step model prescribed under ASU No. 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.

The Company reviews accounts receivable periodically for collectability and establishes an allowance for doubtful accounts and records bad debt expense when deemed necessary. Our allowance for doubtful accounts is maintained to provide for losses arising from customers’ inability to make required payments. If there is deterioration of our customers’ credit worthiness and/or there is an increase in the length of time that the receivables are past due greater than the historical assumptions used, additional allowances may be required. The Company has no accounts receivables and therefore as of September 30, 2022 and 2021, no allowance for doubtful accounts is necessary.

The Company follows the asset and liability method of accounting for future income taxes. Under this method, future income tax assets and liabilities are recorded based on temporary differences between the carrying amount of assets and liabilities and their corresponding tax basis. In addition, the future benefits of income tax assets including unused tax losses, are recognized, subject to a valuation allowance to the extent that it is more likely than not that such future benefits will ultimately be realized. Future income tax assets and liabilities are measured using enacted tax rates and laws expected to apply when the tax liabilities or assets are to be either settled or realized. The Company’s effective tax rate approximates the Federal statutory rates.

In the summer of 2014, the Company decided to discontinue all operations. After the change of control on November 3, 2020, the Company’s operations are determined and structured by the new major shareholder.

During the three and nine months ended September 30, 2022 and 2021, we generated no revenues.

Operating expenses, during the three months ended September 30, 2022, was $9,925 compared to $13,107 during the three months ended September 30, 2021, a decrease of $3,182 or 24%. Operating expenses during the nine months ended September 30, 2022, was $36,035 compared to $43,764 during the nine months ended September 30, 2021, a decrease of $7,729 or 18%. The decrease was mainly due to the lower professional fees.

During the three months ended September 30, 2022, the Company incurred a net loss of $9,925, compared to a net loss of $13,107 during the three months ended September 30, 2021, a decrease of 3,182. During the nine months ended September 30, 2022, the Company incurred a net loss of $36,035, compared to a net loss of $43,764 during the nine months ended September 30, 2021, a decrease of $7,729. The decrease in net loss in the three and nine months ended September 30, 2022 was primarily due to the decrease in operating expenses.

As of September 30, 2022 and 2021, we had a cash balance of $0. Due to the lack of revenue, the company’s operations are primarily funded by the Company’s CEO and major shareholder.

To the extent that the Company’s capital resources are insufficient to meet current or planned operating requirements, the Company will seek additional funds through equity or debt financing, collaborative or other arrangements with corporate partners, licensees or others, and from other sources, which may have the effect of diluting the holdings of existing shareholders. The Company has no current arrangements with respect to, or sources of, such additional financing and the Company does not anticipate that existing shareholders will provide any portion of the Company’s future financing requirements. Ms. Xudong, the CEO and principal shareholder of the Company, would favorably entertain funding, through loans, corporate expenses for approximately 24 months. Any loans by Ms. Xudong would be on an interest-free basis, documented by a promissory note and payable only upon consummation of a business combination transaction. Upon consummation of a business combination, we or the target may reimburse Ms. Xudong for any such loans from funds furnished by the target. We have no written agreement with Ms. Xudong to advance any further funds for future operating expense, therefore there is no assurance that such funds from Ms. Xudong will be forth coming, if required.

No assurance can be given that additional financing will be available when needed or that such financing will be available on terms acceptable to the Company. If adequate funds are not available, the Company may be required to delay or terminate expenditures for certain of its programs that it would otherwise seek to develop and commercialize. This would have a material adverse effect on the Company. These factors raise substantial doubt about the ability of the Company to continue as a going concern.

Net cash used in operating activities was $0 during the nine months ended September 30, 2022 and 2021.

We neither generated nor used cash in investing activities during the nine months ended September 30, 2022 and 2021.

We neither generated nor used cash in financing activities during the nine months ended September 30, 2022 and 2021.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, we have incurred net losses of $36,035 and $43,764 for the nine months ended September 30, 2022 and 2021, respectively, and have a working capital deficit of $89,211 as of September 30, 2022, in addition to a stockholders’ deficit of $89,211, which raise substantial doubt about the Company’s ability to continue as a going concern.

Management believes the Company will continue to incur losses and negative cash flows from operating activities for the foreseeable future and will need additional equity or debt financing to sustain its operations until it can achieve profitability and positive cash flows, if ever. Management plans to seek additional debt and/or equity financing for the Company but cannot assure that such financing will be available on acceptable terms.

The Company’s continuation as a going concern is dependent upon its ability to ultimately attain profitable operations, generate sufficient cash flow to meet its obligations, and obtain additional financing as may be required. Our auditors have included a “going concern” qualification in their Report of Independent Certified Public Accountants accompanying our audited financial statements appearing elsewhere herein which cites substantial doubt about our ability to continue as a going concern. Such a “going concern” qualification may make it more difficult for us to raise funds when needed. The outcome of this uncertainty cannot be assured.

The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. There can be no assurance that management will be successful in implementing its business plan or that the successful implementation of such business plan will actually improve our operating results.

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors

We do not believe that inflation has had in the past or will have in the future any significant negative impact on our operations.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

Based upon an evaluation of the effectiveness of our disclosure controls and procedures performed by our Chief Executive Officer as of the end of the period covered by this report, our Chief Executive Officer concluded that our disclosure controls and procedures were not effective as a result of a weakness in the design of internal control over financial reporting identified below.

As used herein, “disclosure controls and procedures” mean controls and other procedures of our company that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

There have been no changes in our internal controls over financial reporting during the period ended September 30, 2022 that have materially affected or are reasonably likely to materially affect our internal controls.

In the ordinary course of business, we are from time to time involved in various pending or threatened legal actions. The litigation process is inherently uncertain and it is possible that the resolution of such matters might have a material adverse effect upon our financial condition and/or results of operations. However, in the opinion of our management, other than as set forth herein, matters currently pending or threatened against us are not expected to have a material adverse effect on our financial position or results of operations.

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

*XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections. In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are furnished and not filed.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

i Nevada		i 91-2154289
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

i Room 2707, Global Mansion, i Zhengbian Road, i Jinhui District, i Zhengzhou City, Henan Province		i 450000, i China
(Address of principal executive offices)		(Zip Code)

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		HGYN		OTCMarkets (OTCQB)

Large accelerated filer ☐		Accelerated filer ☐

i Non-accelerated filer ☐		Smaller reporting company i ☒

Emerging growth company i ☐


	September 30,			December 31,
	2022			2021
	Unaudited
ASSETS
TOTAL ASSETS	$	-		$	-

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts payable and accrued liabilities	$	i 900		$	-
Due to related parties		i 88,311			i 53,176
Total Current Liabilities		i 89,211			i 53,176

TOTAL LIABILITIES		i 89,211			i 53,176

Stockholders’ Deficit
Preferred Stock: i i 5,000,000 / shares authorized; $ i i 0.001 / par value i i i i 5,000,000 / / / issued and outstanding at September 30, 2022 and December 31, 2021		i 5,000			i 5,000
Common stock: i i 250,000,000 / shares authorized; $ i i 0.001 / par value i i i i 74,640,766 / / / shares issued and outstanding at September 30, 2022 and December 31, 2021		i 74,641			i 74,641
Additional Paid-in Capital		i 97,186,036			i 97,186,036
Accumulated deficit during development stage		( i 97,354,888	)		( i 97,318,853	)
Total Stockholders’ Deficit		( i 89,211	)		( i 53,176	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	-		$	-


	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2022			2021			2022			2021

Operating Expenses
General and administrative	$	i 30		$	i 1,755		$	i 5,109		$	i 5,255
Professional fees		i 9,895			i 11,352			i 30,926			i 38,509
Total Operating Expenses		i 9,925			i 13,107			i 36,035			i 43,764

Operating loss		( i 9,925	)		( i 13,107	)		( i 36,035	)		( i 43,764	)

Other Income and Expense		-			-			-			-

Provision for income taxes		-			-			-			-

Net loss	$	( i 9,925	)	$	( i 13,107	)	$	( i 36,035	)	$	( i 43,764	)

Basic and dilutive net loss per common share	$	( i 0.00	)	$	( i 0.00	)	$	( i 0.00	)	$	( i 0.00	)

Weighted average number of common shares outstanding - basic and diluted		i 74,640,766			i 74,640,766			i 74,640,766			i 74,641,039

Hong Yuan Holding Group – ‘10-Q’ for 9/30/22

On: Monday, 11/14/22, at 5:01pm ET · For: 9/30/22 · Accession #: 1493152-22-32213 · File #: 0-56252

Previous ‘10-Q’: ‘10-Q’ on 8/15/22 for 6/30/22 · Next: ‘10-Q’ on 5/15/23 for 3/31/23 · Latest: ‘10-Q’ on 11/13/23 for 9/30/23

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Quarterly Report

Document Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

PART I – FINANCIAL INFORMATION		3

ITEM 1	Condensed Consolidated Financial Statements (Unaudited)	3

ITEM 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11

ITEM 3	Quantitative and Qualitative Disclosures About Market Risk	14

ITEM 4	Controls and Procedures	14

PART II – OTHER INFORMATION		15

ITEM 1	Legal Proceedings	15

ITEM 1A	Risk Factors	15

ITEM 2	Unregistered Sales of Equity Securities and Use of Proceeds	15

ITEM 3	Defaults Upon Senior Securities	15

ITEM 4	Mine Safety Disclosures	15

ITEM 5	Other Information	15

ITEM 6	Exhibits	15

31.1		Certification of CEO and CFO. Filed herewith.
32.1		Certification pursuant to 18 U.S.C. Section 1350 of CEO and CFO. Filed herewith.
101.INS*		XBRL Instance Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Definition
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document
101.LAB*		XBRL Taxonomy Extension Label Linkbase Document
104*		Cover Page Interactive Data File (embedded within the Inline XBRL document)

	HONG YUAN HOLDING GROUP

Dated: November 14, 2022	By:	/s/ Li Xudong
		Li Xudong
		CEO and Chief Financial Officer (chief financial and accounting officer and duly authorized officer)

This ‘10-Q’ Filing	Date	Other Filings

	12/31/22
Filed on:	11/14/22
	11/9/22
For Period end:	9/30/22
	6/30/22	10-Q
	12/31/21	10-K
	9/30/21	10-Q
	6/30/21	10-Q
	5/27/21
	12/31/20
	11/18/20
	11/3/20
	5/4/20
	5/1/20
	4/15/20
	4/14/20
	4/13/20
	3/11/20
	10/4/19
	6/4/19
	3/22/19
	1/1/18
	3/27/14
	2/21/14
	2/14/14	8-K
	2/10/14	8-K
	2/3/14	8-K
	1/31/14
	4/5/13	8-K, DEF 14A, PRE 14A
	8/24/12	8-K
	3/18/05
	7/19/04
	9/29/01
	9/14/01
		List all Filings